Allan Tillack, Chairman of GBMA, talks about sustainability in generic medicines, aggressive pricing in Australian medicines and the use of biosimilars to gain easier access to medications. #app2016
Read moreAllan Tillack
Find Us On Facebook
Top Videos
Social researcher Mark McCrindle will be unpacking the findings of
A large-scale pilot program testing the efficacy of real-time monitoring
Recent Comments
Ryan WilloughbyMarch 21, 2016 at 3:19 pm
Guy Callum PowerMarch 21, 2016 at 7:28 am
jonMarch 17, 2016 at 7:54 pm